Status | Study |
Recruiting |
Study Name: High-intensity Focused Ultrasound (HIFU) for the Symptom Relief of Inoperable Abdominal Tumors Condition: Symptomatic Abdominal Tumour Date: 2017-05-11 Interventions: Device: High-intensity focused ultrasound Local tumor ablation by ArcBlate (EpiSonica, Taiwan) will be p |
Not yet recruiting |
Study Name: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children Condition: Malignant Neoplasms of Mesothelial and Soft Tissue Rhabdomyosarcoma, Pelvic Date: 2017-04-06 Interventions: Procedure: Abdominal Surgery |
Not yet recruiting |
Study Name: EDMONd - Elemental Diet in Bowel Obstruction Condition: Ovarian Cancer Ovarian Neoplasms Ovarian Disease Date: 2017-04-03 Interventions: Dietary Supplement: Elemental 028 Extra Liquid A nutritionally complete, liquid elemental diet consistin |
Recruiting |
Study Name: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Condition: Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Pe Date: 2017-03-22 Interventions: Drug: Ixabepilone |
Recruiting |
Study Name: Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block Condition: Postoperative Analgesia Lower Abdominal Cancer Date: 2017-02-17 Interventions: Drug: Ketamine Ketamine at a d |
Recruiting |
Study Name: Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain Condition: Abdominal Cancer Date: 2017-02-10 Interventions: Device: Radiofrequency generator device |
Not yet recruiting |
Study Name: QUILT-2.021: Phase I of IP Followed by SQ ALT-803 for Ovarian Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Ca Date: 2017-02-10 Interventions: Biological: ALT-803 Subcutaneous |
Recruiting |
Study Name: Assessing How Normal Variations in CT Scanning Affects Its Interpretation Condition: Colorectal Cancer Metastatic Date: 2017-01-30 Interventions: Diagnostic Test: CT scan Patients with colorectal liver metastases scheduled for abdominopelvic CECT wil |
Recruiting |
Study Name: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Peritoneal Neoplasms Date: 2017-01-30 Interventions: Drug: Paclitaxel Paclitaxel 17 |
Recruiting |
Study Name: IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery Condition: Stage III Fallopian Tube Cancer Stage III Ovarian Cancer S Date: 2017-01-10 Interventions: Drug: Carboplatin Given IV |